Autoimmunity linked to COVID-19 immunization has been recorded throughout the
pandemic. Herein we present six new patients who experienced relapses of previous …

To date, around 60% of the world population has been protected by vaccines against SARS-
CoV-2, significantly reducing the devastating effect of the pandemic and restoring social …

Background There are a growing number of case reports of various autoimmune diseases
occurring after COVID-19, yet there is no large-scale population-based evidence to support …

Conclusions SARS‐CoV‐2 vaccination can be associated with liver injury. Corticosteroid
therapy may be beneficial in those with immune‐mediated features or severe hepatitis …

Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel
vaccine platform based on mRNA technology was introduced to the market. Globally, around …

Oxidative stress is a pivotal point in the pathophysiology of COVID-19 and presumably also
in Long-COVID. Inflammation and oxidative stress are mutually reinforcing each other, thus …

In 2011, a syndrome entitled ASIA (Autoimmune/inflammatory Syndrome Induced by
Adjuvants; Shoenfeld's syndrome) was first described. ASIA aimed to organize under a …

Background Case reports suggest that SARS-CoV-2 infection could lead to immune
dysregulation and trigger autoimmunity while COVID-19 vaccination is effective against …

Several studies have utilized a lipid nanoparticle delivery system to enhance the
effectiveness of mRNA therapeutics and vaccines. However, these nanoparticles are …

Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect
multiple organs. Reports of persistent or newly emergent symptoms, including those related …